IDXX My $405 position remains a high-conviction hold. While I monitor the emerging risks, IDEXX's exceptional fundamentals and disciplined long-term strategy continue to justify my confidence in this quality compounder.
IDEXX Laboratories, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
No trades
Community discussions
IDXX My $405 position remains a high-conviction hold. While I monitor the emerging risks, IDEXX's exceptional fundamentals and disciplined long-term strategy continue to justify my confidence in this quality compounder.IDXX IDEXX is entering its Q3 earnings with significant positive momentum, driven by strong growth forecasts for its veterinary diagnostics segment. Optimism is high, fueled by the successful adoption of new products like the AI-powered inVue Dx Analyzer. Investors are closely watching for continued strength in its pet healthcare business to confirm the stock's robust performance.